Vitamin K2 administration is associated with decreased disease activity in patients with rheumatoid arthritis

REFERENCES

• Liu Y, Nelson AN, Lipsky JJ. Vitamin K-dependent carboxylase: mRNA distribution and effects of vitamin K deficiency and warfarin treatment. Biochem Biophys Res Commun. 1996;224: 549–54.
   Google Scholar
• Yamaguchi M, Taguchi H, Gao YH, Igarashi A, Tsukamoto Y. Effect of vitamin IC2 (menaquinone-7) in fermented soybean (natto) on bone loss in ovariectomized rats. J Bone Miner Metab. 1999;17: 23–9.
   Google Scholar
• Akiyama Y, Hara K, Tajima T, Murota S, Morita I. Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures. Eur J Pharmacol. 1994;263: 181–5.
   Google Scholar
• Hirao M, Hashimoto J, Ando W, Ono T, Yoshikawa H. Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women. J Bone Miner Metab. 2008;26: 260–4.
   Google Scholar
• Suzuki K, Tsuji S, Fukushima Y, Nakase T, Hamada M, Tomita T, et al. Clinical results of alendronate monotherapy and com-bined therapy with menatetrenone (VitK(2)) in postmenopausal RA patients. Mod Rheumatol. 2012 (in press).
   Google Scholar
• Suttie JW. Synthesis of vitamin K-dependent proteins. FASEB J. 1993;7:445–52.
   PubMed Web of Science ®Google Scholar
• Yaguchi M, Miyazawa K, Katagiri T, Nishimaki J, Kizaki M, Tohyama K, et al. Vitamin K2 and its derivatives induce apop-tosis in leukemia cells and enhance the effect of all-trans retinoic acid. Leukemia. 1997;11:779–87.
   PubMed Web of Science ®Google Scholar
• Yaguchi M, Miyazawa K, Otawa M, Katagiri T, Nishimaki J, Uchida Y, et al. Vitamin K2 selectively induces apoptosis of blastic cells in myelodysplastic syndrome: flow cytometric detection of apoptotic cells using AP02.7 monoclonal antibody. Leukemia. 1998;12:1392–7.
   PubMed Web of Science ®Google Scholar
• Fujita H, Tomiyama J, Tanaka T. Vitamin K2 combined with all-trans retinoic acid induced complete remission of relapsing acute promyelocytic leukaemia. Br J Haematol. 1998;103: 584–5.
   Google Scholar
• Miyazawa K, Nishimaki J, Ohyashiki K, Enomoto S, Kuriya S, Fukuda R, et al. Vitamin K2 therapy for myelodysplastic syn-dromes (MDS) and post-MDS acute myeloid leukemia: infor-mation through a questionnaire survey of multi-center pilot studies in Japan. Leukemia. 2000;14:1156–7.
   PubMedGoogle Scholar
• Qu Z, Garcia CH, O'Rourke LM, Planck SR, Kohli M, Rosen-baum JT. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum. 1994;37:212–20.
   Google Scholar
• Nakazawa F, Matsuno H, Yudoh K, Katayama R, Sawai T, Uzuki M, et al. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis. J Rheumatol. 2001;28:1800–8.
   PubMedGoogle Scholar
• Okamoto H, Shidara K, Hoshi D, Kamatani N. Anti-arthritis effects of vitamin K(2) (menaquinone-4)-a new potential therapeutic strategy for rheumatoid arthritis. FEBS J. 2007;274:4588–94.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Com-parison of Disease Activity Score (DAS)28-erythrocyte sedi-mentation rate and DA528-C-reactive protein threshold values. Ann Rheum Dis. 2007;66: 407–9.
   Google Scholar
• Steinbrocker 0, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949;140:659–62.
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 1992;35:498–502.
   PubMed Web of Science ®Google Scholar
• Catrina AT, Ulfgren AK, Lindblad S, Grondal L, Klareskog L. Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium. Ann Rheum Dis. 2002;61:934–6.
   Google Scholar
• Franz JK, Pap T, Hummel KM, Nawrath M, Aicher WK, Shi-geyama Y, et al. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum. 2000;43:599–607.
   Google Scholar
• Perlman H, Liu H, Georganas C, Koch AE, Shamiyeh E, Haines GK 3rd, et al. Differential expression pattern of the antiapoptotic proteins, Bc1-2 and FLIP, in experimental arthritis. Arthritis Rheum. 2001;44: 2899–908.
   Google Scholar
• Schedel J, Gay RE, Kuenzler P, Seemayer C, Simmen B, Michel BA, et al. FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheuma-toid arthritis. Arthritis Rheum. 2002;46:1512–8.
   PubMedGoogle Scholar
• Kim WU, Yoo SA, Min SY, Park SH, Koh HS, Song SW, et al. Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes. Clin Exp Immunol. 2006;144:503–11.
   PubMed Web of Science ®Google Scholar
• Wunder A, Schellenberger E, Mahmood U, Bogdanov A Jr, Muller-Ladner U, Weissleder R, et al. Methotrexate-induced accumulation of fluorescent annexin V in collagen-induced arthritis. Mol Imaging. 2005;4:1–6.
   Google Scholar
• Criddle DN, Gillies S, Baumgartner-Wilson HK, Jaffar M, Chinje EC, Passmore S, et al. Menadione-induced reactive oxygen species generation via redox cycling promotes apoptosis of murine pancreatic acinar cells. J Biol Chem. 2006;281:40485–92.
   Google Scholar
• Mokuda S, Okuda Y, Onishi M, Sawada N, Matoba K, Yamada A, et al. Postmenopausal women with rheumatoid arthritis who are treated with raloxifene or alendronate or glucocorticoids have lower serum undercarboxylated osteocalcin (uc0C) levels. J Endocrinol Invest. 2012;35:661–4.
   PubMed Web of Science ®Google Scholar
• Oelzner P, Muller A, Deschner F, Huller M, Abendroth K, Hein G, et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int. 1998;62:193–8.
   PubMed Web of Science ®Google Scholar
• Muller K, Kriegbaum NJ, Baslund B, Sorensen OH, Thymann M, Bentzen K. Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol. 1995;14: 397–400.
   Google Scholar